Dopamine Enhancing Agents Flashcards

(76 cards)

1
Q

How do we increase dopaminergic action in striatum?

A
Augmentation of the synthesis of brain DA
Stimulation of DA release
Direct stimulation of DA receptor
Decreasing DA reuptake
Decreasing metabolism of DA and DOPA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Secondary therapeutic goal in PD

A

Decrease endogenous ACh action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why worry about ACh?

A

ACh has an overall stimulating effects on muscle contraction (while DA inhibits muscle contracting so not enough = tremor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

So what happens in PA?

A

Not enough DA to counteract ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why can’t you administer DA?

A

It is completely destroyed during digestion
It cannot be absorbed by the gut wall
Must be given IV and even then it can’t cross BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

So L-dopa works how?

A

It is decarboxylated to DA

L-dopa is transported across BBB via large neutral amino acid transporter (LAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

L-dopa half life and problems

A

0.5-2 hrs
Has to compete with neutral amino acids so don’t take it with lots of proteins
Also rapid peripheral decarboxylation so always given with an inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Levodopa SE

A

Nausea
Dyskinesias
Hallucinations, postural hypoTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Long-term treatment with levodopa leads to

A

Motor complications

  • Waring off and response fluctuations
  • Dyskinesias (involuntary movements)
  • Feeling stuck to the floor
  • Therapeutic window becomes narrower with longer treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Levodopa Absorption

A

Bioavailablity of 30% but doubled when given with a decarboxylase inhibitor
Delayed/reduced with food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Levodopa Metabolism and Excretion

A

M: Liver/gut/kidney
E: Kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Decarboxylase Inhibitor =

A

Carbidopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Decarboxylase Inhibitor MOA

A

Inhibits the peripheral metabolism of L-dopa to DA which increases amount of levadopa which increase the amount of DA in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carbidopa Brands

A

Sinernel
Rytary
Lodosyn (monotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Carbidopa helps to

A

Relieve nausea and other side effects of Levadopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

COMT Inhibitors do what?

A

Diminish response fluctuations
Adjunct to L-dopa/carbidopa
Blocks L-DOPA to 3-o-MD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

COMT Inhibitors Drugs

A

Talcapone (Tasmar)

Entacapone (Comtan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Talcapone Brand

A

Tasmar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Talcapone MOA

A

Inhibits COMT centrally and peripherally

Long duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Talcapone SE

A

jaundice, upset stomach, extreme tiredness, hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Talcapone Black Box Warning

A

Risk of potentially fatal, acute fulminant liver failure so requires blood test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Talcapone Use

A

Only used in patients not responding to other treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Entacapone Brand

A

Comtan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Entacapone MOA

A

Inhibits COMT peripherally

Preferred over Tolcapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Carbidopa + Levodopa + Entacapone =
Stalevo
26
Entacapone SE
Nausea Orthostatic hypotension 0 Less severe
27
Entacapone + MAOI?
Only selegiline
28
MAO-A
Preferentially deaminates serotonin, epinephrine and NE leading to unwanted serious side effects
29
MAO-B
Resonsible for oxidative deamination of DA in the brain
30
So is MAOB or A more desired?
MAO-B should be selectively inhibited
31
MAO-B Inhibitors
Selegiline (Eldepryl, Emsam, Zelapar) | Rasagiline (Azilect)
32
Selegiline
Eldepryl Emsam Zelapar
33
Selegiline is what type of inhibitor?
Irreversible MAO-B Inhibitor
34
Low dose verse high dose Selegiline
Low: MAOB High: both A and B
35
Selegiline Use
1st drug of choice in pts under 65 Monotherapy in early PD Adjunct in advanced PD
36
Metabolites of Selegiline
Amphetamine and methamphetamine
37
Selegiline SE
Anxiety and insomnia | Hallucinations
38
Selegiline Drug Interactions
Meperidine (serotonin syndrome, CV instability)
39
Transdermal patch and orally disintegrating pill of selegiline?
Reduce 1st pass metabolism and limits the formulation of metabolites so there are less side effects
40
Rasagiline brand
Azilect
41
Rasagiline MOA
irreversible MAO-B Inhibitor
42
Rasagiline upside
Not metabolized to amphetamines so less side effects
43
Rasagiline use
Monotherapy in early or adjunct with levadopa in advanced PD
44
Ergot derivatives that are Dopamine Receptor Agonists
Bromocriptine | - Rarely used nowadays bc they are older
45
Most common Dopamine Receptor Agonists
Pramipexole | Rapirnirole
46
Define Indirect Pathway
Inhibits movement
47
Define Direct Pathway
Enables movement
48
What does Dopamine do to the pathways?
It inhibits the indirect pathway (blocks inhibition of movements) and stimulates the direct pathway (increase movement)
49
So how do dopamine agonist work?
Directly stimulates dopamine receptors
50
Dopamine Agonists upsides
Longer half lives No toxic metabolites No competition for transporter
51
Dopamine Agonist Uses
Initial therapy esp in young and adjunct to levadopa
52
Monotherapy dopamine agonist
Ropinirole and pramipexole
53
Dopamine agonists SE
``` N/V Dizziness Drowsiness/somnolence Confusion hallucinations Dyskinesias with levadopa Fibrosis (ergots) ```
54
Ropinirole brand
Requip
55
Ropinrole MOA
``` D2 class receptor selectivity 6 hr half life and last 8-24 hours ```
56
Ropinirole SE
Somnolence Hallucination/confusion Orthostatic hypotension
57
Ropinirole Use
Treating on/off effects
58
Pramipexole Brand
Mirapex
59
Pramipexole MOA
D2 class receptor selectivey 8 hr half life 90% bioavailability
60
Pramipexole AE
N Somnolence Sleepiness (sudden falling asleep)
61
Apomorphine brand
Apokyn | - Oldest and most potent dopamine agonist
62
Apomorphine Use
``` SC injection Rescue medication (pts with irregular off periods) ```
63
Apomorphine SE
Highly nauseating | Orthostatic hypotension
64
Rotigotine Brand and dosage form
Neupro | - Transdermal patch
65
Rotigotine MOA
Selective D2 receptor agonist | halflife 5-7 hrs
66
Rotigotine Use
PD and restless leg syndrome
67
Anti-cholinergic agent MOA
Anti-PD blcoks msucarinic receptors or inhibit DA reuptake | DA depletion leads to increased cholinergic activity (tremor)
68
Decreased dopaimine leads too
Inhibited ACh through D2 | Increased ACh which leads to tremor
69
Muscarinic receptor antagonists?
Benzlropine (Cogentin) | Trihexyphenidyl (Artane)
70
Anticholinergic agent Use
Tremor
71
Anticholinergic agents + older pts
Worsening dementia so CI in alzheimer's
72
Anticholinergic SE
``` Dry mouth Constipation Urinary retention Sedation/confusion Delirium ```
73
Amantadine brand
Symmetrel
74
Amantadine MOA
Antiviral drug used for flu Enhances DA release and inhibits its reuptake Has anticholinergic properties Blocks NMDA receptors
75
Amantadine Use
Mild PD
76
Amantadine SE
``` Confusion Dizziness Hallucinations Dry mouth Livedo reticularis (mottling of skin) ```